Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 18 - DISEASE REPORTING › Section 333-018-0015 - What Is to Be Reported and When

Current through Register Vol. 63, No. 7, July 1, 2024
(1)
			 Health care providers shall report all human cases or suspected human cases of
			 the diseases, infections, microorganisms, intoxications, and conditions
			 specified below. The timing of health care provider reports is specified to
			 reflect the severity of the illness or condition and the potential value of
			 rapid intervention by public health agencies.
(2) Licensed laboratories shall report all
			 test results indicative of and specific for the diseases, infections,
			 microorganisms, intoxications, and conditions specified below for humans. Such
			 tests include but are not limited to: microbiological culture, isolation, or
			 identification; assays for specific antibodies; and identification of specific
			 antigens, toxins, or nucleic acid sequences.
(3) Human reportable diseases, infections,
			 microorganisms, intoxications, and conditions, and the time frames within which
			 they must be reported are as follows:
(a)
			 Immediately, day or night:
(A) Select
			 biological agents and toxins: Avian influenza virus; Bacillus anthracis
			 (anthrax); Bacillus cereus biovar anthracis; Botulinum neurotoxins; Botulinum
			 neurotoxin-producing species of Clostridium; Brucella (brucellosis);
			 Burkholderia mallei (glanders); Burkholderia pseudomallei (melioidosis);
			 Conotoxins; Clostridium botulinum (botulism); Coxiella burnetii (Q fever);
			 Crimean-Congo hemorrhagic fever virus; Diacetoxyscirpenol; Eastern Equine
			 Encephalitis virus; Ebola virus; Francisella tularensis (tularemia); Hendra
			 virus; Lassa fever virus; Lujo virus; Marburg virus; Mpox (Monkeypox) virus;
			 Newcastle disease virus; Nipah virus; Reconstructed replication-competent forms
			 of the 1918 pandemic influenza virus containing any portion of the coding
			 regions of all eight gene segments (Reconstructed 1918 Influenza virus); Ricin;
			 Rickettsia prowazekii (louse-borne typhus); Rift Valley fever virus; Severe
			 Acute Respiratory Syndrome (SARS) and infection by SARS coronavirus; Saxitoxin
			 (paralytic shellfish poisoning); South American Hemorrhagic Fever viruses
			 (Chapare, Guanarito, Junin, Machupo, Sabia); Staphylococcal enterotoxins
			 A,B,C,D,E subtypes; T-2 toxin; Tetrodotoxin (puffer fish poisoning); Tick-borne
			 encephalitis complex (flavi) viruses (Far Eastern subtype, Siberian subtype);
			 Kyasanur Forest disease virus; Omsk hemorrhagic fever virus, Variola major
			 (Smallpox virus); Variola minor virus (Alastrim); Yersinia pestis
			 (plague).
(B) The following other
			 infections, microorganisms, and conditions: Corynebacterium diphtheriae
			 (diphtheria); novel influenza; poliomyelitis; rabies (human); measles
			 (rubeola); rubella; Vibrio cholerae O1, O139, or toxigenic (cholera); yellow
			 fever; intoxication caused by marine microorganisms or their byproducts (for
			 example, domoic acid intoxication, ciguatera, scombroid);
(C) Any known or suspected disease outbreak,
			 including any outbreak associated with health care, regardless of whether the
			 disease, infection, microorganism, or condition is specified in this rule;
			 and
(D) Any uncommon illness of
			 potential public health significance.